Your browser doesn't support javascript.
loading
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting ß2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England.
Requena, Gema; Banks, Victoria; Czira, Alexandrosz; Wood, Robert; Tritton, Theo; Wild, Rosie; Compton, Chris; Ismaila, Afisi S.
Afiliación
  • Requena G; Value Evidence and Outcomes, GSK, R&D Global Medical, Brentford, Middlesex, UK.
  • Banks V; Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK.
  • Czira A; Value Evidence and Outcomes, GSK, R&D Global Medical, Brentford, Middlesex, UK.
  • Wood R; Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK.
  • Tritton T; Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK.
  • Wild R; Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK.
  • Compton C; Value Evidence and Outcomes, GSK, R&D Global Medical, Brentford, Middlesex, UK.
  • Ismaila AS; Value Evidence and Outcomes, GSK, Collegeville, PA, USA.
Article en En | MEDLINE | ID: mdl-36908830

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Peloideterapia Asunto principal: Antagonistas Muscarínicos / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Peloideterapia Asunto principal: Antagonistas Muscarínicos / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido